Cellromax Science Co., Ltd. (KOSDAQ:471820)
5,230.00
-10.00 (-0.19%)
At close: Apr 23, 2026
2.15% (1Y)
| Market Cap | 58.07B +11.2% |
| Revenue (ttm) | 22.18B +2.6% |
| Net Income | 2.97B -22.3% |
| EPS | 261.00 -28.9% |
| Shares Out | 11.04M |
| PE Ratio | 20.15 |
| Forward PE | n/a |
| Dividend | 185.00 (3.54%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 10,899 |
| Average Volume | 27,214 |
| Open | 5,280.00 |
| Previous Close | 5,240.00 |
| Day's Range | 5,140.00 - 5,280.00 |
| 52-Week Range | 4,560.00 - 7,690.00 |
| Beta | n/a |
| RSI | 56.70 |
| Earnings Date | May 21, 2026 |